SCHEMBL6169080

SCHEMBL6169080

CCOC(=O)c1ccc(NC(=O)CCc2ccccc2Cl)c([N+](=O)[O-])c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.62
MAPT P10636 8/20 0.60
ALDH1A1 P00352 8/20 0.55
RAB9A P51151 4/20 0.55
NPC1 O15118 2/20 0.55
PKM P14618 1/20 0.55
CRHBP P24387 1/20 0.55
CRHR2 Q13324 1/20 0.55
POLB P06746 2/20 0.54
LMNA P02545 1/20 0.54
KDM4E B2RXH2 1/20 0.54
PTGER4 P35408 1/20 0.53
HTT P42858 2/20 0.52
AGTR1 P30556 1/20 0.52
MEN1 O00255 3/20 0.47
MAPK1 P28482 1/20 0.47
GAA P10253 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
THRB P10828 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6170387 0.92 HTT (0.54) KMT2AMAPTALDH1A1RAB9ANPC1
SCHEMBL6170314 0.89 KMT2A (0.61) KMT2AMAPTALDH1A1RAB9ANPC1
SCHEMBL6170391 0.82 KMT2A (0.53) KMT2AMAPTALDH1A1RAB9ANPC1
SCHEMBL6170461 0.82 L3MBTL1 (0.53) KMT2AMAPTALDH1A1RAB9ANPC1
SCHEMBL6170367 0.81 KMT2A (0.52) KMT2AMAPTALDH1A1RAB9ANPC1
SCHEMBL9043092 0.81 KMT2A (0.72) KMT2AMAPTALDH1A1RAB9ANPC1
SCHEMBL6169309 0.81 KMT2A (0.49) KMT2AMAPTALDH1A1RAB9ANPC1
SCHEMBL6171238 0.80 RAB9A (0.52) KMT2AMAPTALDH1A1RAB9ANPC1
SCHEMBL6169345 0.79 KMT2A (0.69) KMT2AMAPTALDH1A1RAB9ANPC1
SCHEMBL6168153 0.78 POLB (0.49) KMT2AMAPTALDH1A1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882718-B1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2005-08-31 EP disclosed
US-6352985-B1 CARDIOVASCULAR DISORDERS OR GASTROINTESTINAL DISORDERS, DIABETES (TYPE II DIABETES), DIABETIC COMPLICATIONS METHOD FOR LOWERING THE BLOOD SUGAR LEVEL OF A PATIENT, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-05 US disclosed
US-6166219-A Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-12-26 US disclosed
EP-0882718-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-09 EP disclosed